Published in Ital J Pediatr on April 20, 2010
Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease. Physiol Genomics (2010) 0.87
Leptin in pediatrics: A hormone from adipocyte that wheels several functions in children. Indian J Endocrinol Metab (2012) 0.81
Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 16.98
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
Angiogenesis modulates adipogenesis and obesity. J Clin Invest (2007) 3.23
Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension (2006) 3.01
Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev (2000) 2.94
Intracellular signalling pathways activated by leptin. Biochem J (2006) 2.93
Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem (1999) 2.18
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A (2001) 2.11
Vascular endothelial growth factor in children with congenital heart disease. Ann Thorac Surg (2003) 1.57
Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest (2007) 1.49
The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res (1997) 1.31
Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem (2002) 1.28
Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes (2004) 1.25
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res (2000) 1.22
Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2003) 1.00
Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg (2000) 0.98
Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res (2001) 0.96
Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatr Cardiol (2002) 0.96
Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs. Am J Physiol Heart Circ Physiol (2004) 0.91
Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol (2005) 0.89
Changing concepts of the pulmonary plexiform lesion. Physiol Res (2000) 0.88
Clinical insights into the pathogenesis of primary pulmonary hypertension. Chest (1998) 0.87
Increased vascular endothelial growth factor in patients with cyanotic congenital heart diseases may not be normalized after a Fontan type operation. Ann Thorac Surg (2004) 0.87
Angiogenesis: basic pathophysiology and implications for disease. Eur Heart J (2003) 0.86
Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol (2003) 0.86
The hypoxia-inducible factor HIF-1 promotes intramyocardial expression of VEGF in infants with congenital cardiac defects. Basic Res Cardiol (2007) 0.85
Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters. Int J Cardiol (2003) 0.84
Pulmonary hypertension in infancy and childhood. Heart Dis (2001) 0.81
Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure. Exp Physiol (2007) 0.79
Mechanism of myocardial microvessel formation in cyanotic congenital heart disease. Circ J (2005) 0.77
Pyrimidine nucleoside phosphorylase from Haemophilus influenzae. Methods Enzymol (1978) 0.77
Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome. Pediatr Res (2008) 0.82
Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density. J Pediatr Hematol Oncol (2010) 0.80
Dyslipidemia, oxidative stress and cardiac dysfunction in children with chronic renal failure: effects of L-carnitine supplementation. Ann Saudi Med (2006) 0.77